Helena Costa Verdera

1.9k total citations · 2 hit papers
10 papers, 1.2k citations indexed

About

Helena Costa Verdera is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Helena Costa Verdera has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Oncology. Recurrent topics in Helena Costa Verdera's work include Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (3 papers). Helena Costa Verdera is often cited by papers focused on Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (3 papers). Helena Costa Verdera collaborates with scholars based in France, United States and Italy. Helena Costa Verdera's co-authors include Federico Mingozzi, Klaudia Kuranda, Pieter Vader, Jerney J. Gitz-Francois, Raymond M. Schiffelers, Fanny Collaud, Christian Leborgne, Solenne Marmier, Romain Hardet and Giuseppe Ronzitti and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Controlled Release.

In The Last Decade

Helena Costa Verdera

9 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

2020 446 citations Helena Costa Verdera, Klaudia Kuranda et al. Molecular Therapy profile →
Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis

2017 402 citations Helena Costa Verdera, Jerney J. Gitz-Francois et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helena Costa Verdera France	7	917	535	219	189	109	10	1.2k
Ashley M. Jacobi United States	17	1.5k 1.7×	366 0.7×	163 0.7×	173 0.9×	164 1.5×	25	1.9k
Alessio Cantore Italy	17	1.2k 1.3×	905 1.7×	378 1.7×	268 1.4×	159 1.5×	30	1.7k
James K. Wahl United States	29	1.6k 1.7×	413 0.8×	319 1.5×	147 0.8×	131 1.2×	48	2.4k
Michael Naso United States	14	1.1k 1.2×	556 1.0×	290 1.3×	109 0.6×	313 2.9×	28	1.8k
Robert Kutner United States	14	723 0.8×	388 0.7×	218 1.0×	98 0.5×	113 1.0×	18	1.2k
Giridhara R. Jayandharan India	27	1.6k 1.7×	1.2k 2.3×	232 1.1×	83 0.4×	98 0.9×	83	2.3k
Leszek Lisowski Australia	25	1.7k 1.9×	1.2k 2.2×	252 1.2×	84 0.4×	77 0.7×	80	2.3k
Paola Rimessi Italy	22	1.1k 1.2×	285 0.5×	415 1.9×	91 0.5×	107 1.0×	49	1.6k
Stephanie Laufs Germany	22	824 0.9×	574 1.1×	394 1.8×	89 0.5×	179 1.6×	59	1.3k
Alessandro Bertero United States	21	1.6k 1.8×	197 0.4×	149 0.7×	173 0.9×	70 0.6×	35	2.2k

Countries citing papers authored by Helena Costa Verdera

Since Specialization

Citations

This map shows the geographic impact of Helena Costa Verdera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Costa Verdera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Costa Verdera more than expected).

Fields of papers citing papers by Helena Costa Verdera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Costa Verdera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Costa Verdera. The network helps show where Helena Costa Verdera may publish in the future.

Co-authorship network of co-authors of Helena Costa Verdera

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Costa Verdera. A scholar is included among the top collaborators of Helena Costa Verdera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Costa Verdera. Helena Costa Verdera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Verdera, Helena Costa, Carmen Unzu, Sahil Adriouch, et al.. (2023). Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors. Human Gene Therapy. 34(17-18). 836–852. 17 indexed citations

Verdera, Helena Costa, Klaudia Kuranda, & Federico Mingozzi. (2020). AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer. Molecular Therapy. 28(3). 723–746. 446 indexed citations breakdown →

Poupiot, Jérôme, Helena Costa Verdera, Romain Hardet, et al.. (2019). Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy — Methods & Clinical Development. 15. 83–100. 19 indexed citations

Armour, Sean M., Francesco Puzzo, Umut Cagin, et al.. (2019). Safety and efficacy evaluation of investigational liver gene transfer for secretable GAA in the treatment of Pompe disease. Molecular Genetics and Metabolism. 126(2). S24–S24.

Armour, Sean M., Helena Costa Verdera, Daniëlle Cohen, et al.. (2019). O.6Pre-clinical development of SPK-3006, an investigational liver-directed AAV gene therapy for the treatment of Pompe disease. Neuromuscular Disorders. 29. S39–S39. 2 indexed citations

Colella, Pasqualina, Helena Costa Verdera, Francesco Puzzo, et al.. (2018). AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice. Molecular Therapy — Methods & Clinical Development. 12. 85–101. 54 indexed citations

Boisgérault, Florence, Romain Hardet, Solenne Marmier, et al.. (2018). Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications. 9(1). 4098–4098. 203 indexed citations

Kuranda, Klaudia, Christian Leborgne, Romain Hardet, et al.. (2018). Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation. 128(12). 5267–5279. 78 indexed citations

Verdera, Helena Costa, Jerney J. Gitz-Francois, Raymond M. Schiffelers, & Pieter Vader. (2017). Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. Journal of Controlled Release. 266. 100–108. 402 indexed citations breakdown →

10.

Vidal, Pierre, Giuseppe Ronzitti, Fanny Collaud, et al.. (2017). Adeno associated vector-based gene therapy strategy for type 3 glycogen storage disease. Neuromuscular Disorders. 27. S246–S246. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact